Jagsonpal Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

34.81

27.32

21.87

9.41

9.00

Net cashflow-operating activity

46.66

5.60

28.22

11.25

30.90

Net cash used in investing activity

-57.67

-26.21

-2.26

-10.76

-0.83

Netcash used in fin. activity

-0.46

-12.30

-6.83

-0.94

-6.05

Net inc/dec in cash and equivlnt

-11.47

-32.91

19.13

-0.46

24.02

Cash and equivalnt begin of year

22.53

58.94

39.81

38.53

14.51

Cash and equivalnt end of year

11.05

26.03

58.94

38.07

38.53